您的位置：首页 > 产品中心 > Dox-NPTM (5mL vial)
Dox-NPTM (5mL vial)
| 产品编号： | 4071484 |
| 规格： | Dox-NP® (Liposomal Encapsulated Doxorubicin), frozen liposomal suspension (buffer-10% w/w sucrose, 10 mM histidine ~pH 6.5) |
| 包装规格： | 1 EA |
| 产品类别： | 进口试剂 |
| 品牌： | Avanti |
| 优惠价： | 立即咨询 |
产品别名
Dox-NPTM (5mL vial)
Dox-NP (5mL vial)
基本信息
| NACRES | NA.25 |
| General description【一般描述】 | Formulation: A Pegylated, long-circulating liposomal formulation with doxorubicin entrapped within an ammonium sulfate core via remote-loading. All unencapsulated was removed to yield a completely liposomal doxorubicin product. Liposomes are stored frozen for a longer shelf life. |
| Application【应用】 | Dox-NP™(5mL vial) has been used as a sample to study its characteristics by asymmetrical-flow field flow fractionation (MD-AF4). It may also be used as an intravenous (i.v.) injection in flank or orthotopic animal models of cancer. |
| Legal Information【法律信息】 | Avanti is a registered trademark of Avanti Polar Lipids, Inc. Dox-NP is a trademark of Avanti Polar Lipids, Inc. |
产品性质
| Assay【测定】 | >99% (HPLC/MS) |
| manufacturer/tradename | Avanti Polar Lipids |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −20℃ |
| packaging【包装】 | 10 mL amber serum vial (300115S-1EA) |
安全信息
| Pictograms【象形图】 | GHS08 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H340 - H350 |
| Precautionary Statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Hazard Classifications【危险分类】 | Carc. 1B - Muta. 1B |
| Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
